Amount Raised
$40 Million
Round Type
series a
Description
DeepCure, a leader in developing novel, small molecule therapeutics using the world’s largest AI drug discovery engine, announced today the closing of a $40 million Series A financing round led by Morningside Ventures, with participation from existing investors TLV Partners, Sapir Venture Partners, and Benon Group Ltd. The Company has raised a total of $47 million in financing since its inception.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech